Your session is about to expire
← Back to Search
TRIZIVIR + Efavirenz for HIV
Study Summary
This trial will compare the effect of two different HIV treatments on viral load.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Find a Location
Who is running the clinical trial?
Media Library
- I haven't had radiation, chemotherapy, or immune-affecting drugs in the last 4 weeks.I have not had an HIV vaccine in the last 3 months nor plan to during the study.I am committed to completing the study and taking the drugs as required.If I am under 18, my parent or guardian has agreed to the treatment.I have a stomach or intestine problem that affects how I absorb medicine.I am not allergic to the study drugs or their ingredients.I have been on anti-HIV medication for at least 2 weeks.I am 13 years old or older.I have had hepatitis in the last 6 months.I need medication effective against HIV.I have taken medication for HIV that is not a nucleoside.I am not taking astemizole, cisapride, midazolam, triazolam, or ergot derivatives.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To what extent can this medical treatment be harmful to individuals?
"Our safety rating for this treatment is a 3 because it has advanced to Phase 4, which demonstrates the efficacy and acceptability of said medication."
What criteria are needed to be eligible for this investigation?
"This study requires 400 individuals with HIV to take part and they must fall in the age bracket of 13 to 80 years old."
What is the geographical scope of this research?
"This clinical trial is currently enrolling patients from 42 different sites, with locations ranging from New Orleans to Washington. It may be beneficial for potential participants to choose the clinic closest to them in order to reduce travelling time and costs if they decide to join the study."
Does the eligibility criteria for this medical experiment extend to those aged 70 and older?
"This clinical trial has set a minimum age of 13 and an upper limit at 80 years old. Meanwhile, there are 108 studies for minors and 352 trials targeting those over 65."
Are there any vacancies for enrollees in this experiment?
"The clinicaltrial.gov records reflect that this study is not currently in search of participants, despite having been first submitted on February 1st 2001 and last updated June 23rd 2005. However, there are presently 484 other studies actively recruiting patients."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger